TGTX-102

N/A

Report date: 2026/01/28 09:08:50

Base Information

Drug NameTGTX-102
Drug Alias NameTSHA-104TGTX-102
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV9 vector
Mechanisms of ActionSurfeit locus protein 1 gene transference
TargetsSurfeit locus protein 1
Therapy Area/IndicationsLeigh Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesTaysha Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsLeigh Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A